Our Technology

Connective Orthopaedics’ products stimulate the healing of intra-articular tissues (tissues found inside joints). Our first product has been developed to encourage the healing of anterior cruciate ligament (ACL) injuries and improve the long term outcome for the patient. Treatment of these injuries is one of the most challenging problems in the orthopaedic arena today. These tissues have minimal intrinsic ability to repair or regenerate, and are traditionally treated by excision of the injured tissue and replacement with self (autograft) or donor tissue (allograft). Although considered successful, these procedures have a higher occurrence of premature knee osteoarthritis and consequently have a substantial impact on the patient’s lifestyle.

Connective Orthopaedics has exclusively licensed its core technology from Children's Hospital Boston and Vanderbilt University. The technology was developed in the laboratory of Dr. Martha Murray at Children’s Hospital Boston and from Dr. Kurt Spindler’s Laboratory at Vanderbilt University Medical School. The potential of the technology to improve clinical outcomes for soft tissue injuries has been demonstrated and reported in both the scientific and clinical communities over the last decade.